Literature DB >> 22378351

Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.

Takashi Kinoshita1, Nijiro Nohata, Haruko Watanabe-Takano, Hirofumi Yoshino, Hideo Hidaka, Lisa Fujimura, Miki Fuse, Takeshi Yamasaki, Hideki Enokida, Masayuki Nakagawa, Toyoyuki Hanazawa, Yoshitaka Okamoto, Naohiko Seki.   

Abstract

Our expression signatures of human cancers including head and neck squamous cell carcinoma (HNSCC) demonstrated that downregulation of microRNA-133a (miR-133a) were frequently observed in cancer cells. The restoration of miR-133a in cancer cells revealed that it functions as a tumor suppressor. In this study, we investigated the novel molecular targets of miR-133a in HNSCC cancer cells and its oncogenic function, especially as it contributes to cancer cell migration and invasion. The genome-wide gene expression analysis and bioinformatics study showed that actin-related protein 2/3 complex subunit 5 (ARPC5) is a candidate target of miR-133a. Furthermore, luciferase reporter assay demonstrated that ARPC5 is directly regulated by miR-133a. Silencing of ARPC5 revealed significant inhibition of cell migration and invasion in HNSCC cell lines, SAS, HSC3 and IMC-3. In HSC3 cells, restoration of miR-133a or silencing ARPC5 led to a reorganization of the actin cytoskeleton and a subsequent change in cell morphology to a round, bleb-like shape. The expression levels of ARPC5 were significantly higher in HNSCC tissues than in non-cancer tissues. Immunohistochemistry showed that the levels of ARPC5 expression were significantly higher in invasive cancer cells. ARPC5 contributed to cancer cell migration and invasion in HNSCC and this gene was directly regulated by miR-133a. Our analysis of novel tumor-suppressive miR‑133a-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378351     DOI: 10.3892/ijo.2012.1390

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  41 in total

1.  Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.

Authors:  Sharareh Siamakpour-Reihani; Kouros Owzar; Chen Jiang; Peter M Scarbrough; Oana I Craciunescu; Janet K Horton; Holly K Dressman; Kimberly L Blackwell; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2015-03-26       Impact factor: 3.914

2.  Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.

Authors:  Zhaofeng Chen; Xiaoguang Liu; Zenan Hu; Yuping Wang; Min Liu; Xiaojun Liu; Hailong Li; Rui Ji; Qinhong Guo; Yongning Zhou
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

3.  Identification of key genes and construction of microRNA-mRNA regulatory networks in bladder smooth muscle cell response to mechanical stimuli using microarray expression profiles and bioinformatics analysis.

Authors:  Liao Peng; De-Yi Luo
Journal:  World J Urol       Date:  2017-11-15       Impact factor: 4.226

4.  Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.

Authors:  Nancy M Cladel; Lynn R Budgeon; Timothy K Cooper; Karla K Balogh; Neil D Christensen; Roland Myers; Vladimir Majerciak; Deanna Gotte; Zhi-Ming Zheng; Jiafen Hu
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

5.  Genetic heterogeneity within collective invasion packs drives leader and follower cell phenotypes.

Authors:  Elizabeth L Zoeller; Brian Pedro; Jessica Konen; Bhakti Dwivedi; Manali Rupji; Niveda Sundararaman; Lei Wang; John R Horton; Chaojie Zhong; Benjamin G Barwick; Xiaodong Cheng; Elisabeth D Martinez; Matthew P Torres; Jeanne Kowalski; Adam I Marcus; Paula M Vertino
Journal:  J Cell Sci       Date:  2019-10-09       Impact factor: 5.285

6.  Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C.

Authors:  Hiroko Mataki; Hideki Enokida; Takeshi Chiyomaru; Keiko Mizuno; Ryosuke Matsushita; Yusuke Goto; Rika Nishikawa; Ikkou Higashimoto; Takuya Samukawa; Masayuki Nakagawa; Hiromasa Inoue; Naohiko Seki
Journal:  J Hum Genet       Date:  2014-12-18       Impact factor: 3.172

Review 7.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26

8.  Arp2/3 complex inhibitors adversely affect actin cytoskeleton remodeling in the cultured murine kidney collecting duct M-1 cells.

Authors:  Daria V Ilatovskaya; Vladislav Chubinskiy-Nadezhdin; Tengis S Pavlov; Leonid S Shuyskiy; Viktor Tomilin; Oleg Palygin; Alexander Staruschenko; Yuri A Negulyaev
Journal:  Cell Tissue Res       Date:  2013-09-15       Impact factor: 5.249

Review 9.  Actin binding proteins: their ups and downs in metastatic life.

Authors:  Stephane R Gross
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

10.  microRNA-133a exerts tumor suppressive role in oral squamous cell carcinoma through the Notch signaling pathway via downregulation of CTBP2.

Authors:  Wei Liu; Xiaoming Shi; Baoliang Wang
Journal:  Cancer Gene Ther       Date:  2021-02-02       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.